Heart Lung Machine Market Report 2025 (Global Edition)

Global Heart Lung Machine Market Report 2025 Market Size Split by Product Type (Cardiopulmonary Bypass Machine, Extracorporeal Membrane Oxygenation (ECMO) Machine, Assist Devices), by Application (Hea...

Heart Lung Machine Market Report Description

We have various report editions of Heart Lung Machine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

In 2025, Terumo Cardiovascular Group announced the acquisition of Vascutek, a leading provider of cardiovascular devices.
https://www.terumocv.com/about/ 
In April 2023, Abbott CentriMag Blood Pump System, a next-generation heart-lung machine that offers improved patient outcomes and reduced complications receives new FDA Clearances.
https://abbott.mediaroom.com/2023-04-25-Abbotts-Life-Support-System-Receives-New-FDA-Clearances-to-Help-Doctors-Treat-More-Critically-Ill-Patients 
In August 2023, Medtronic issued an Urgent Medical Device Communication regarding updated patient management recommendations for HVAD systems, which the FDA agrees with. 
https://www.fda.gov/medical-devices/cardiovascular-devices/medtronic-heartware-ventricular-assist-device-hvad-system#:~:text=Update:%20August%2025%2C%202023,place%20in%20a%20clinical%20setting. 
In March 2023, LivaNova PLC introduced the Essenz Heart-Lung Machine (HLM) and Essenz Patient Monitor to enhance clinical efficiency and elevate patient care during CPB procedures.  
https://investor.livanova.com/news-releases/news-release-details/livanova-receives-us-fda-510k-clearance-essenz-heart-lung 
 

Top Companies Market Share in Heart Lung Machine Industry: (In no particular order of Rank)

• Roche Diagnostics
• LivaNova PLC
• BD
• Siemens Healthineers
• Abbott
• Stryker
• Terumo Cardiovascular Systems
• Medtronic
• Fresenius SE KGa a
• HemoCue AB
• Natus Medical Incorporated
• Maquet
• Zoll Medical Corporation
• Sorin Group
• Getinge AB
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region will dominate the Market in 2025, and Which Region is Expanding at the Fastest CAGR?
According to Cognitive Research, North America region dominated the market and accounted for the highest revenue of XX% in 2024 and it is projected that it will grow at a CAGR of XX% in the future. North America possesses highest heart lung machine market share and is influenced by a number of key drivers. To begin with, the growing incidence of cardiovascular diseases and allied surgical interventions necessitates sophisticated cardiopulmonary support systems, which are offered by heart-lung machines. The aging population also plays an important role in driving the market, as elderly people are more susceptible to heart ailments that need surgical interventions. Also, advancements in heart-lung machines, such as better safety features and increased functionalities, appeal to healthcare facilities seeking to maximize patient outcomes. 
For instance, in 2023, 4.8% of US adults reported ever having been diagnosed with coronary heart disease.
https://www.cdc.gov/nchs/fastats/heart-disease.htm#:~:text=Percent%20of%20adults%20who%20have,Health%20Interview%20Survey%2C%202019%2D2023 
The increasing number of heart surgeries, combined with increased investment in healthcare facilities, further propels demand for these devices. Additionally, research and development efforts to innovate and enhance the performance of heart-lung machines will drive the market ahead. Lastly, government support and funding for cardiovascular research add to the overall growth potential within this segment.
Asia Pacific is estimated to grow at a CAGR of XX% during the period. The Asia Pacific region is likely to see tremendous market growth in the forecast period. The growth is driven by several factors, including an aging population, high incidence of CVD, and well-developed healthcare infrastructure. Moreover, positive government policies, growing awareness of CPB machines, and high spending on research and development activities are the drivers for the growth of the market. These factors together promote the adoption and demand for CPB machines, thus resulting in the overall growth of the market in the Asia Pacific region. 
For instance, cardiovascular disease (CVD) is a significant global health issue, and the Centers for Disease Control and Prevention (CDC) offers extensive information and resources on its occurrence and risk factors, including within the Asia-Pacific region.
https://www.cdc.gov/heart-disease/risk-factors/index.html#:~:text=Heart%20disease%20is%20the%20leading,3 
 

The current report Scope analyzes Heart Lung Machine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Heart Lung Machine Market Analysis

Heart Lung Machine Market is segmented by product type into Cardiopulmonary Bypass Machines, Extracorporeal Membrane Oxygenation (ECMO) Machines, and Assist Devices. Based on the product type, Cardiopulmonary Bypass segment accounted for XX% of market share in 2024. This prevalence is owing to the general application of cardiopulmonary bypass procedures in cardiac operations, for example, coronary artery bypass grafting and valve replacement. The Heart Lung Bypass Machine Market is recording strong growth due to a high incidence of cardiovascular diseases, an aging population, and developments in medical technology. Hospitals and surgical facilities are utilizing these machines more frequently to improve patient outcomes and surgical accuracy. Also, innovations that result in smaller, more efficient devices are supporting market growth.
For instance, Medtronic a medical technology leader, has a wide portfolio of cardiopulmonary products. Medtronic is poised to take advantage of the increasing demand for cardiovascular surgeries and equipment. The company plans to expand its product offerings through ongoing innovation and strategic acquisitions.
https://www.medtronic.com/in-en/our-company.html 
The Extracorporeal Membrane Oxygenation (ECMO) Machine market is likely to experience substantial growth during the forecast period due to the rising incidence of respiratory failure and the expanding use of ECMO as a life-saving therapy.
For instance, in 2023, BreathMo, an advanced ECMO system, was launched at the ASAIO Conference, symbolizing China's domestic innovation in medical technology. The innovative maglev technology serves the specific medical demands of Chinese patients, constituting a landmark advancement in the sector.
https://en.magassist.com.cn/Corporate/2023-ASAIO.html 
The spreading nature of cardiovascular diseases, growing popularity of minimally invasive surgeries, and advancements in heart-lung machines are the key driving factors for the growth of the market.
 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Heart Lung Machine Industry. Request a Free Sample PDF!

Application Segment Analysis of Heart Lung Machine Market

This report analyzes revenue growth in the {Keyword} market across global, regional, and national levels, highlighting trends and opportunities for each application. It examines how sectors like diagnostics, therapy, and monitoring utilize devices to meet healthcare needs. Key factors include market size, revenue contributions, technological innovations (e.g., AI diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. (For more information, please request a sample or contact our research team)
 

Some of the key Application of Heart Lung Machine are:

• Heart Surgery
• Lung Surgery
• Cardiac Arrest
• Respiratory Failure

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Heart Lung Machine Patient Age Segment Analysis

• Neonates
• Children
• Adults

Heart Lung Machine Flow Rate Segment Analysis

• Low Flow (less than 1 L/min)
• Medium Flow (1-2 L/min)
• High Flow (greater than 2 L/min)

Heart Lung Machine Number of Circuits Segment Analysis

• Single-Circuit Machines
• Dual-Circuit Machines
• Multi-Circuit Machines

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion